AbbVie Community Guidelines - Curatio
match,apps that connect patients with heart disease,best canadian digital health apps,novartis,connect,type 1 diabetes patient support group,thalassaemia,matchmaking,peer support groups for thalassemia,thalassaemia patient connections,apps that connect patients,thalassemia support group,dragon’s den health app,private chat with thalassaemia patients,digital health apps,medical apps that connect patients,apps that increase patient engagement for pharmaceutical companies,social health apps that connect patients,patients,how to increase patient engagement in hospitals,apps that increase patient acquisition for hospitals,communities,how pharmaceuticals increase patient engagement,lynda brown,how to increase patient retention in hospitals,apps that track symptoms,peer,private chat with heart disease patients,apps to connect people with type 1 diabetes,support,thalassaemia connect patinets
page-template-default,page,page-id-16967,ajax_fade,page_not_loaded,,qode_grid_1300,qode-theme-ver-10.1.1,bridge,wpb-js-composer js-comp-ver-5.0.1,vc_responsive

AbbVie Community Guidelines

AbbVie Care Circle community guidelines

Thank you for visiting AbbVIe Care Circle. We would love to hear from you, and  have you join the many conversations going on between your fellow AbbVie Care members.  However, as with any civilized exchange of ideas, we need to lay down a few ground rules for everyone to follow when posting, which you will find in the guidelines below. Essentially, the guidelines are a list of reasons why you or another user’s comments may be removed from the discussion. Avoiding the content discussed in the guidelines will help keep the forum a friendlier, safer, more respectful environment – which is exactly what we set out to create.

User Guidelines

This forum is a place for you to share ideas. While we encourage openness and discussion, AbbVie Care  is subject to government regulations concerning online content, whether posted directly by AbbVie Care or any of our Web site visitors. For this reason, users are asked to refrain from discussing any of the specific topic areas listed below. The use of vulgar or offensive language is prohibited. In addition, we ask that users remain respectful in their comments. Any posts which do not meet these simple rules will be removed.


Please note that this forum is monitored at all times by an automated tool. We may have to retrieve your contact information and to contact you in case of an adverse event or product complaint


Topics to Avoid

  • Prescription products, including HUMIRA, and their benefits or side effects
  • Off-label discussion
  • Requests for or offers of medical advice or treatment suggestions
  • Recommendations, criticisms, or subjective ratings of specific clinics or health care professionals
  • Promotional information or offers of commercial services or products
  • Criticisms of or opinions on other forum users or AbbVie and its employees
  • Reporting of adverse events related to HUMIRA treatment. There are specific channels for reporting adverse events.